Xcorporeal Inc (XCRP)
Xcorporeal, Inc. (OTC Markets: XCRP) is a common stock listing tied to a company that entered liquidation and dissolution after its board approved that course on February 4, 2010. To carry out the wind-down, the company established Xcorporeal, Inc. Liquidating Trust and transferred its assets to that trust for completion of the process. Before liquidation, Xcorporeal operated as a medical device company focused on developing extra-corporeal platform technology intended for devices designed to replace the function of various human organs. The company was founded in 2001 and is based in Lake Forest, California.
Stock Summary
Fair Value
Profitability & Growth
Quality & Risk
Events & Dividends
Technical Outlook
FAQ
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-XCRP
|
—
|
—
|
—
|
—
|
—
|
—
|
Fair
|
—
|
—
|
—
|
0.0%
|
—
|
—
|
—
|
—
|
0.015 K
|
—
|
—
|
—
|
—
|
—
|
—
|
